Heartbeam Inc. (BEAT)
NASDAQ: BEATHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BEAT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $17.42M
- EPS (TTM)
- -$0.39
- Dividend yield
- None
- 52-week range
- 0.2727 – 4.00
- Day range
- 0.2727 – 0.314
- Volume / Avg
- 658.30K / 7.50M
- Beta
- —
- Shares outstanding
- 63.31M
52-week range
BEAT stock today
On Nov 20, BEAT ended the session at $0.2751, shedding $0.0338 (10.94%), versus the S&P 500's 3.70% decline. Trading was light, with 658.30K shares changing hands, about 9% of the average daily volume. At this level, BEAT sits near the bottom of its 52-week range of $0.2727 to $4.00: 93.1% below the high, set on Dec 17, 2025 and 0.9% above the low.
BEAT is down 88.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 64.8%. Heartbeam has posted a net loss over the last twelve months (EPS of -$0.39), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Heartbeam
Company profileHeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Headquarters
- Santa Clara, CA
- Employees
- 16
- IPO year
- 2021
- Website
- heartbeam.com
Financial highlights
Full financialsHeartbeam reported a net loss of $21.0 million, compared with a loss of $19.4 million a year earlier. Diluted earnings per share came in at -$0.62.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Growth | — | — | — | — | — |
| Net income | $-21.02M | $-19.45M | $-14.64M | $-12.96M | $-4.43M |
| EPS (diluted) | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 |
Analyst forecast
ForecastConsensus (3 analysts)
buy
Avg. price target
$3.50+1172.26%
- Strong buy 1
- Buy 1
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $-0.05 vs $-0.09
- Surprise
- +44.44%
BEAT news
All BEAT newsHeartbeam peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PMIPicard Medical Inc. | 6.79 | +7.78% | $18.07M | vs BEAT |
| RVPRetractable Technologies Inc. | 0.558 | -6.84% | $16.70M | vs BEAT |
| MODDModular Medical Inc. | 1.68 | -11.81% | $16.36M | vs BEAT |
| DRIODarioHealth Corp. | 1.32 | -8.33% | $14.90M | vs BEAT |
| CVRXCVRx Inc. | 0.501 | -5.99% | $14.27M | vs BEAT |
| CTSOCytosorbents Corporation | 4.16 | -18.91% | $13.12M | vs BEAT |
| SNWVSANUWAVE Health Inc. | 1.50 | -5.66% | $12.90M | vs BEAT |
| DAVIDavion Healthcare Plc | 0.9001 | -9.99% | $22.50M | vs BEAT |
Indexes, lists and sector
Heartbeam stock FAQ
What is Heartbeam's stock price today?
BEAT last traded at $0.2751 as of Nov 20, 4:00 PM EST, down 10.94% on the day. Prices are delayed at least 15 minutes.
What is the BEAT 52-week high?
The 52-week high for BEAT is $4.00 and the 52-week low is $0.2727. The stock is currently 93.1% below its high.